OUTPUT
Live / Applied — Final refusal mailed (as of 07 Oct 2025)
What this means for you
Not registered yet, but its 03 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97617393
- Mark type
- Stylized text
- Filed
- 03 Oct 2022
- Attorney of record
- Trina A. Longo
Goods and services
- Class 005 — Pharmaceuticals: Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, using targeted bioactives for the modulation of disturbed microbial ecosystems; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, via targeted modulation of a host microbial community; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for the prevention and treatment of human diseases, namely, Autoimmune diseases and disorders, Bone and joint diseases and disorders, Cancer, Cardiovascular diseases and disorders, Gastro-intestinal diseases and disorders, Hematologic diseases and disorders, Infectious diseases and disorders, Kidney diseases and disorders, Lung diseases and disorders, Metabolic diseases and disorders, Muscle diseases and disorders, Nephrology diseases and disorders, Neurodegenerative diseases and disorders, Neurological diseases and disorders, Ophthalmic diseases and disorders, Dermatological diseases and disorders, Inflammatory diseases and disorders, Immune disorders, Allergic disorders, Immuno-oncology and improving therapy outcome of Immuno-oncology therapies, Psychiatric diseases and disorders, Digestive diseases and disorders, Nutritional diseases and disorders, Malnutrition, Vaginal and penile diseases and disorders, Dysbioses, Fertility
- Class 042 — Scientific and technological services: Computational biology platform for preventative therapies and nutraceuticals, namely non-downloadable software in the field of computational biology for use in the discovery, design, and optimization of therapeutics, pharmaceuticals, preventative therapies, and nutraceuticals; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in the research, development, and identification of disease mechanisms and therapeutic targets within the human microbiome; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in designing, forecasting results, running, and monitoring clinical trials, and selecting clinical trial participants, all related to clinical trials for therapeutics, pharmaceuticals, preventative therapies and nutraceuticals; Product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and nutraceuticals; research and development of therapeutics related to preventative therapies, pharmaceuticals, and nutraceuticals
Owner
- OUTPUT BIOSCIENCES INC., NEW YORK, NY, US
- Jingu Health Inc., New York, NY, US
Prosecution history
- 06 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 06 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 07 Oct 2025 — FINAL REFUSAL E-MAILED
- 07 Oct 2025 — FINAL REFUSAL WRITTEN
- 25 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Dec 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Dec 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED